Bo Angelin
Professor
Medicine
Karolinska Institutet
Sweden
Biography
Bo Angelin is Professor of Clinical Metabolic Research at KI and Consultant at the Department of Endocrinology, Metabolism & Diabetes (Head 1993-2011) at Karolinska University Hospital, where he has also served as Director of Research. His research interest is regulation of lipid and cholesterol metabolism with special emphasis on humans, and how this knowledge can be used for development of new forms of diagnostics and treatments.
Research Interest
Regulation of lipid and cholesterol metabolism with special emphasis on humans
Publications
-
Angelin B. Fifty years of lipoprotein (a)–the Magical Mystery Tour continues. Journal of internal medicine. 2013 Jan 1;273(1):3-5.
-
Angelin B, Kristensen JD, Eriksson M, Carlsson B, Klein I, Olsson AG, Chester Ridgway E, Ladenson PW. Reductions in serum levels of LDL cholesterol, apolipoprotein B, triglycerides and lipoprotein (a) in hypercholesterolaemic patients treated with the liverâ€selective thyroid hormone receptor agonist eprotirome. Journal of internal medicine. 2015 Mar 1;277(3):331-42.
-
Angelin B, Rudling M. Lipid lowering with thyroid hormone and thyromimetics. Current opinion in lipidology. 2010 Dec 1;21(6):499-506.
